- ►aspetjournals.org S Hu, S Wang, B Fanelli, PA Bell, BE Dunning … - Journal of Pharmacology and Experimental …, 2000 - ASPET Nateglinide (A-4166) is an amino acid derivative with insulinotrophic action in
clinical development for treatment of type 2 diabetes. The aim of this study was
to determine whether nateglinide's interaction at the K ATP ... Cited by 115 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org [PDF] ES Horton, C Clinkingbeard, M Gatlin, J Foley … - Diabetes Care, 2000 - Am Diabetes Assoc From the Joslin Diabetes Center (ESH), Boston, Massachusetts; the Idaho
Endocrine Specialists (CC), Boise, Idaho; the Cardiovascular, Metabolic and
Endocrine Department (MG, SM), Clinical Research Divi- sion; and the ... Cited by 201 - Related articles - BL Direct - All 9 versions
M Hanefeld, KP Bouter, S Dickinson, C … - Diabetes Care, 2000 - Am Diabetes Assoc F rom the Outpatient Department, Institute of Clinical Metabolic Research,
Medical Faculty, Technical Uni- versity of Dresden (MH), Dresden, Germany; Bosch
Medicentre (KPB), Den Bosch, the Netherlands; and N ova rtis Pharma AG (SD, ... Cited by 147 - Related articles - BL Direct - All 7 versions
PA Hollander, SL Schwartz, MR Gatlin, SJ … - Diabetes Care, 2001 - Am Diabetes Assoc RESULTS—During the liquid-meal challenge, nateglinide reduced the incremental
glucose area under the curve (AUC) more effectively than glyburide (Δ = −4.94
vs. −2.71 mmol · h/l, P < 0.05), whereas glyburide reduced fasting ... Cited by 100 - Related articles - BL Direct - All 7 versions
Y Hirschberg, AH Karara, AO Pietri, JF Mc … - Diabetes Care, 2000 - Am Diabetes Assoc Subjects Ta rget enrollment comprised 12 male and female volunteers with type2
diabetes of at least 6 months' duration, between ages 30 and 70 years, within 10
to 60% of their normal weight range, with an HbA 1 c of 12.5%, and with ... Cited by 60 - Related articles - BL Direct - All 4 versions
A Laghmich, L Ladriere, F Malaisse-Lagae, … - Pharmacological Research, 1999 - Elsevier 1. T Yada and S Fujitani, Action mechanisms of a novel hypoglycaemic agent
(A4166) in pancreatic B-cells analyzed by measuring cytosolic Ca concentration.
Diabetes (1992). ... 14. A Sener, F Malaisse-Lagae, SP Dufrane and WJ ... Cited by 14 - Related articles - BL Direct - All 5 versions
- ►endojournals.org L Keilson, S Mather, YH Walter, S … - Journal of Clinical Endocrinology & Metabolism, 2000 - Endocrine Soc This study assessed the synergistic effects of nateglinide (a nonsulfonylurea
D-phenylalanine derivative) and meals on insulin secretion in 24 patients with
type 2 diabetes. Oral doses of 60 and 180 mg or 120 and 240 mg were ... Cited by 90 - Related articles - BL Direct - All 5 versions
AH Karara, BE Dunning, JF McLeod - The Journal of Clinical Pharmacology, 1999 - jclinpharm.highwire.org On behalf of: American College of Clinical Pharmacology ... KARARA ET AL THE IN
SULI NO TROPIC AGENT NATEGLINIDE PHAR MA COKI NET ICS AND PHAR MA CO DY NAM ICS ... The Ef fect of Food on the Oral Bioa vail abil ity Cited by 56 - Related articles - BL Direct - All 6 versions
YH Walter, DI Spratt, S Garreffa, JF McLeod - European journal of clinical pharmacology, 2000 - Springer Abstract Objectives: Pharmacodynamic e ects of nate- glinide, a novel
antidiabetic agent, were investigated in patients with type-2 diabetes mellitus.
Methods: Ten patients participated in this single-center, double-blind, ... Cited by 19 - Related articles - BL Direct - All 4 versions
